MRes Translational Medicine - Pharmaceutical Cancer: The University of Manchester

Course description

NOTE: The MRes in Translational Medicine has 2 pathways:

• Translational Medicine: Interdisciplinary Molecular Medicine (Option A)
• Translational Medicine: Pharmaceutical Cancer Translational Medicine (Option B)

Applicants must select their preferred pathway through the MRes at the online application stage. However, there will be the opportunity to switch pathways following induction to the MRes, should students decide to alter their route through the course.

The MRes in Translational Medicine (MRes TM) is designed to encourage a focused group of high-calibre science and medical students into the field of translational medicine. The growth in importance of translational medicine as a branch of medical science has been significant in recent years as efforts to connect basic research with patient care have multiplied. Across the healthcare industry, translational medicine is pivotal to the advancement of emerging therapies relating to improved pharmaceutical targeting, biomedical technologies and integration with clinical trials.

The aim is to improve and accelerate bench-to-bedside research, i.e. research that reduces the timeframe between emerging molecular, genetic and cellular discoveries and their application to the patient. As biotechnology becomes more sophisticated, the scope exists to improve not only the targeting of medications, but their delivery and outcome prediction. To achieve this, a multitude of systems biology skills are required, including genomics, transcriptomics and proteomics.

Career opportunities

This course will appeal to focused, high-calibre science and intercalating medical students, who want to pursue a career in Translational Medicine at the interface of the biomedical sciences.

Many students will progress into PhD research within the biosciences, a career in academic medicine or take up positions with leading pharmaceutical or biomedical companies.

Entry requirements

Academic entry qualification overview:

An honours degree (minimum 2:1) in the biomedical sciences. International candidates must have obtained the equivalent of a 2:1 in a related degree from a reputed University.

Candidates on the undergraduate medical programme must have satisfactorily completed years 1-4 of the MBChB with no failure at any examination. For St Andrews students this includes their 3 year degree programme and the following 2 years spent in Manchester (years 3 and 4 of the Manchester programme)

Students with evidence of previous advanced study, research or professional experience may be accepted by the University as qualification for entry.

English language: Students whose first language is not English require a minimum of a minimum of IELTS 6.5, or TOEFL 575 paper based or 230 computer based.